OAJ
LGND icon

Ogorek Anthony Joseph’s Ligand Pharmaceuticals LGND Stock Holding History

Ogorek Anthony Joseph’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-67
Closed -$4K – 198
2020
Q4 		$4K Hold
67
– – ﹤0.01% 166
2020
Q3 		$4K Buy
+67
New +$4.57K ﹤0.01% 153
2020
Q2 		– Sell
-67
Closed -$3K – 201
2020
Q1 		$3K Hold
67
– – ﹤0.01% 181
2019
Q4 		$4K Hold
67
– – ﹤0.01% 181
2019
Q3 		$4K Hold
67
– – ﹤0.01% 144
2019
Q2 		$4K Hold
67
– – ﹤0.01% 140
2019
Q1 		$5K Hold
67
– – ﹤0.01% 132
2018
Q4 		$5K Hold
67
– – ﹤0.01% 125
2018
Q3 		$11K Hold
67
– – 0.01% 95
2018
Q2 		$8K Buy
+67
New +$7.48K 0.01% 94

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SDJVC
St. Denis J. Villere & Co New Orleans, Louisiana $907M AUM 10.61% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Ogorek Anthony Joseph's LGND Position: Q1 2021 in Review

Ogorek Anthony Joseph sold out of Ligand Pharmaceuticals (LGND) in Q1 2021, closing a stake of 67 shares — an estimated $4K sold.

Ogorek Anthony Joseph first reported a position in LGND in Q2 2018 and held it in 10 quarters. The position peaked at $11K in Q3 2018. 228 funds tracked by Wall St. Rank hold LGND as of Q1 2021.

  • Ogorek Anthony Joseph reported no remaining Ligand Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • Ogorek Anthony Joseph sold 67 Ligand Pharmaceuticals shares in Q1 2021, an estimated $4K.
  • Ogorek Anthony Joseph first reported a position in Ligand Pharmaceuticals in Q2 2018 and held it in 10 quarters.
  • Ogorek Anthony Joseph's Ligand Pharmaceuticals position peaked at $11K in Q3 2018.
  • 228 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2021.

Based on Ogorek Anthony Joseph's 13F filing for Q1 2021, filed 26 Apr 2021.